All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0773 | Anti-ARHGEF2 (CBFYH-0020) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | CBFYH-0020 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY4026 | Anti-ARHGEF2 (CBFYH-0020) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat | CBFYH-0020 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY999 | Anti-ARHGEF2 (55B6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Human, Monkey | 55B6 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1000 | Anti-ARHGEF2 (B4/7) h(41BB-CD3ζ) CAR, pCDCAR1 | Dog, Human | B4/7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1001 | Anti-ARHGEF2 (GT336) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | GT336 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1002 | Anti-ARHGEF2 (CBLG1-330) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Dog | CBLG1-330 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2639 | Anti-ARHGEF2(55B6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Human, Monkey | 55B6 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2640 | Anti-ARHGEF2(B4/7) h(CD28-CD3ζ) CAR, pCDCAR1 | Dog, Human | B4/7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2641 | Anti-ARHGEF2(GT336) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | GT336 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2642 | Anti-ARHGEF2(CBLG1-330) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Dog | CBLG1-330 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION